Anthranilic acid derivatives useful in treating infection with hepatitis C virus
US7408078B2 · kind B2 · utility
0Cited by
4References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 8, 2003 |
| Grant date | Aug 5, 2008 |
| Priority date | — |
| Expiry date | Aug 31, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D257/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pharmaceutical compositions useful in treating hepatitis C infection. The present invention also provides methods of treating hepatitis C infection by administering to a mammal the pharmaceutical compositions of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.